LXEO
Lexeo Therapeutics, Inc. Common Stock
NASDAQ: LXEO · HEALTHCARE · BIOTECHNOLOGY
$5.70
+0.26% today
Updated 2026-04-30
Market cap
$416.74M
P/E ratio
—
P/S ratio
478.26x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$2 – $11
Volume
0.9M
Lexeo Therapeutics, Inc. Common Stock (LXEO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $29.41M | $136.86M | $97.08M | $139.81M | $146.94M |
| Cash & equivalents | $29.37M | $135.86M | $77.33M | $121.47M | $35.01M |
| Current assets | $29.41M | $136.68M | $80.05M | $124.29M | $126.12M |
| Total liabilities | $34.95M | $192.46M | $210.03M | $26.27M | $30.10M |
| Current liabilities | $697722.00 | $7.45M | $14.35M | $17.24M | $22.85M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $-5.54M | $-55.60M | $-112.95M | $113.53M | $116.84M |
| Retained earnings | $-5.55M | $-56.17M | $-115.45M | $-181.84M | $-280.17M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |